The FDA approved expanded use of Auvelity, an extended release major depressive disorder drug, for use in the treatment of Alzheimer disease.

Glucagon-like peptide-1 receptor agonists have been identified as a potential novel treatment for alcohol use disorder.

Maternal abuse history significantly increases the risk for social-emotional delay in children at age 3 years.

Telehealth and in-person interventions showed similar engagement in care for women with perinatal substance use disorder in a Kentucky trial.

An opioid prediction calculator maintained good predictive performance in patients who received gynecologic surgery to reduce excess postoperative opioid prescribing.